AmerisourceBergen ‘De-Risks’ Home Infusion Market
HME News, Dan Teich
AmerisourceBergen has long offered consulting and startup services through its Pharmacy Solutions division, so when its health system customers said they wanted to add or improve home infusion services, the company built a program to help them do just that, says Dan Teich, vice president of client strategies. “This is the next pivot in the market, based off talking to our customers, to help them de-risk the entry into home infusion,” he said. “It also has to do with payer trends – the idea of shifting patients away from hospital-based infusion centers. It’s really just a growing market.” Teich spoke with HME News about how the growing demand for home infusion services, propelled by the COVID-19 pandemic and the push for health systems to take on increased patient risk, has created an inflection point in the market.
For the full interview, please visit HME News.
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.